What is the approximate price per box of Alpelisib currently sold in the country?

Alpelisib (Alpelisib) is a targeted drug used to treat specific types of breast cancer. It mainly targets patients with PIK3CA mutated HR-positive and HER2-negative advanced breast cancer. As targeted therapy plays an increasingly important role in the treatment of breast cancer, apelvis has received widespread attention due to its specific mechanism of action and clinical efficacy. However, this drug has not yet been approved for marketing in mainland China, and it cannot be purchased directly from domestic pharmacies.

Since Apelvis has not yet been officially launched in China, many domestic patients need to obtain the medication through overseas channels. The more common one is the Indian version of the original drug, which is provided by Novartis in the Indian market, and its price is relatively transparent. The price of the Indian version of Apelvis currently on the market is about more than 3,000 yuan per box. The ingredients of the drug are the same as those of the European and American original versions, and it is favored by some breast cancer patients.

In addition, in order to alleviate the high burden of medication, some patients will choose more affordable versions of generic drugs. It is understood that Lao pharmaceutical companies have launched a generic version of Apelvis. The ingredients of the drug are consistent with the original drug, the specifications are consistent, and the price is relatively low, with each box costing about more than 1,000 yuan. For patients who need to take medication for a long time, this generic version is undoubtedly more economical and accessible.

However, it should be noted that whether it is an original drug from India or a generic drug from Laos, it must be purchased through formal channels to ensure the source and quality of the drug. At the same time, before using Apelvis, you should undergo genetic testing to confirm the existence of PIK3CA mutation, and use the drug rationally under the guidance of a professional doctor to avoid adverse reactions or treatment delays caused by self-purchasing and use of the drug.

Reference materials:https://www.drugs.com/